Efficacy and tolerability of Nitric-Zinc complex in the ...
Recommend Documents
Jung Won Lee,10 Young Jae Im,11. Sang Won Han,11 Jae Min Chung,9. Min Hyun Cho,12 ... Samsung Changwon Hospital, Chnagwon;. 8Department of ...
Quetiapine, a dibenzothiazepine derivative, is an atypical antipsychotic, multireceptor antagonist that has a preclinical profile similar to clozapine. Randomized ...
Aug 19, 2014 - antidepressant or placebo on young patients (age ⤠25 years) who met diagnostic criteria ..... missing dichotomous measure in Cornelius et al.
This is a double-blind, placebo-controlled study of the efficacy, safety, and tolerability of sibutramine in the management of obese patients for a 6-month period.
African Journal of Biomedical Research 2007 (Vol. 10) / Otegbayo, Adedapo, Adedapo, Akere, Aje and Igetei. Efficacy of Meprasilm in Dyspepsia treatment. 230.
autologous SVF cells local injections in patients with SSc .... on D+7 and 13±17 on D+21, and resolved completely at M2. ..... microvascular perfusion. ... 6Department of Radiology, Assistance Publique Hôpitaux de Marseille (AP-HM), Aix-.
Apr 13, 2018 - sleep restriction therapy (SRT) over five weeks as part of another study .... Figure 2 shows charts of all individual participant ISI observations ...
Nov 14, 2014 - Huntington Study Group Reach2HD Investigators*. Summary ...... (University of Melbourne, Kew, VIC); P Agarwal (Booth Gardner ... FL); S Kostyk, A Daley (Ohio State University, Columbus, OH); V Segro,. R Kumar (Colorado ...
Linezolid is a potentially effective drug for the treatment of patients with drug-resistant tuberculosis. Among 13 patients treated for tuber- culosis with linezolid in ...
Mohammad Hossain,c Teri Ashton,b Etienne Dumontb. eStudySite ...... Negash K, Andonian C, Felgate C, Chen C, Goljer I, Squillaci B, Nguyen D,. Pirhalla J ...
creased health care usage, and impaired quality of life. Osteoarthritis of ..... Niethard Fu, Pfeil J. Orthopedie, Hippocrates vertag, Stuttgart. 1989. 21. Mazieres B.
Rl, Robertson kR, de st Maurice aM, currier Js, williams Pl. association of ... 15. baker J, Rainey PM, Moody dE, Morse gd, Ma Q, Mc- cance-katz Ef. Interactions ...
1Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 2Department of. Pediatrics ... (2012;2:33-37). Key words: ...
safe treatment option for patients with major depressive disorder (MDD). The Psychiatric Hospital .... treatment resistant depression (according to the Croatian.
Mar 17, 2013 - type. Yenice et al. [5]. -2a 180 ug/week;. -2b 1.5 ug/kg/week. 800â1200 mg/day. Naıve. 1. 24 or 48. Turkey. 2006. RCT. Di Bisceglie et al.
and tolerability of LDX in child and adolescent ADHD. Any randomized ... alternative medication which is comparable in efficacy and tolerability, with less .... Our hypothesis assumed that each eligible trial outcome was not the same effect ..... a m
Jun 22, 2017 - Cipriani, Andrea; University of Oxford, Department of Psychiatry;. Warneford Hospital, Oxford Health NHS Foundation Trust. Furukawa, Toshi ...
represented by the response rate and retention rate over the study period. ... The retention rate was 54% and ineffectiveness was the most common reason for.
JOAQUIMA ROMERO,3 JUAN TAMARGO,5 LUIS PRIETO,5 JOSE LUIS CARRASCO,2. INMACULADA HERRANZ,5 JOSEFA NAVARRO-CID5 and LUIS M.
oBjectIve: To compare the efficacy, safety, and tolerability of Epalrestat with Methylcobalamine in patients with diabetic neuropathy. MaterIals and Methods: This ...
Dec 20, 2013 - Naples, Florida; **Palliative Care Center Silicon Valley and Hospice of the Valley, San Jose,. California; â â Salix Pharmaceuticals Inc., Raleigh, ...
Sep 30, 2017 - in Treatment of Hypertrophic Scars and Keloids ... numbers to receive intralesional injection of 1 mL of either verapamil (2.5 mg) or triamcinolone (20 mg) every 3 .... nation with other methods, such as cryotherapy (22), flu-.
Efficacy and tolerability of Nitric-Zinc complex in the ...
treatment of condilomata and âdifficult-to-treatâ warts: a âproof of conceptâ, prospective, multicentre, open study. BACKGROUND. Treatment of plantar and ...
Efficacy and tolerability of Nitric-Zinc complex in the treatment of condilomata and “difficult-to-treat” warts: a “proof of concept”, prospective, multicentre, open study Marco Cusini , Giuseppe Micali , Francesco Lacarrubba , Mario Puviani , 4 5 Antonio Barcella , and Massimo Milani 1
2
2
3
1. Sexual Transmitted Disease University of Milan. 2. Dermatology Clinic University of Catania. 3. Dermatology Unit, Ospedale Sassuolo. 4. Dermatology Service, Nembro. 5. ISDIN, Medical Department, Milan.
BACKGROUND
RESULTS
Treatment of plantar and periungueal warts (so called “difficult-to-treat” warts: DTW) and condilomata remains unsatisfactory. Medical or invasive procedures are partially effective and/or painful. Furthermore recurrences rates after treatments are still a relevant problem for all the available therapies. Nitric-Zinc complex is a solution for topical application containing nitric acid, zinc, copper and organic acids able to induce a caustic effect of the wart trough mummification and proteins denaturation/coagulation action. Nitric-Zinc complex has been shown to be an effective and well tolerated treatment of common warts.
All subjects completed the study. A complete cure of lesions was observed in 31 subjects (90%) after 1 and up to four applications. Three patients with condilomata (8%) showed a partial disappearance of lesions and 1 (2%) subject was no responder to four Nitric-Zinc complex applications. The product was well tolerated. Figures show some before and after treatment cases. No serious adverse events were observed or recorded.
STUDY AIM We evaluated in a prospective open label 4-centre trial, the efficacy and local tolerability of Nitric-Zinc complex in the treatment of condilomata and DTW.
SUBJECTS AND METHODS A total of 37 immunocompetent subjects (20 men and 17 women; mean age: 45 years) with single or multiple lesions, were enrolled, after their informed consent. A total of 30 subjects had condilomata, 2 subjects had plantar warts, 2 warts of the hand and 3 peri-ungueal lesions. Nitric-Zinc aqueous solution was applied topically using a 30microL capillary tube over the lesions until a whitening/yellowish reaction appeared. A second (or more, if needed) application was performed at two-week interval until a complete clinical cure rate was observed. Primary outcome of the study was the clinical evaluation with picture documentation of the evolution of lesions classified as total cure, partial disappearance or no effect. Topical tolerability was evaluated through patient’s reported adverse events.
CONCLUSION Nitric-Zinc complex topical solution has shown to be an effective and well tolerated treatment of condilomata and “difficult-to-treat” warts with a 90% of subjects with a total cure after one or up to four applications. A total or partial response was observed in 99% of the subjects. Nitric-zinc complex could be considered an easy-to-use effective treatment strategy of “difficult-to-treat” warts and condilomata. Additional studies comparing Nitric-Zinc complex to other strategies are warranted.